Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.
James SunDennis A KirichenkoJoyce L ChungMichael J CarrZeynep ErogluNikhil I KhushalaniJoseph MarkowitzJane L MessinaVernon K SondakJonathan S ZagerSephalie Y PatelPublished in: World journal of surgery (2020)
Patients undergoing treatment with ICI or targeted therapies can safely undergo surgery without substantially increased risk of serious intraoperative and postoperative complications.